{"id":470967,"date":"2021-04-05T12:30:29","date_gmt":"2021-04-05T16:30:29","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470967"},"modified":"2021-04-05T12:30:29","modified_gmt":"2021-04-05T16:30:29","slug":"shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/","title":{"rendered":"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WILMINGTON, Del., April  05, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8MnPU6LxdYyyQOGl7CM696MJm6uAkKdG1w4oU5bViUvjmtEhwMnXxc4ZrYaSync-IBlR5A5gsd-i_mzO-EO2TtP1vzeJ3nBDeYOfgPCOhaY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Rigrodsky Law, P.A.<\/a> announces that it is investigating Millendo Therapeutics, Inc. (\u201cMillendo\u201d) (NASDAQ GS: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yxDn6gOqwHTYdM7TfAtt209JH0geSDfKWvHAxdtlspfLHg53AzOiKFmXy4o29UKmNIWrGCCpfWq9SWWQ7rEsMIWolrW0OPCxEsj_fSVbZkM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">MLND<\/a>) regarding possible breaches of fiduciary duties and other violations of law related to Millendo\u2019s agreement to merge with Tempest Therapeutics, Inc.<\/p>\n<p>To learn more about this investigation and your rights, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CKnZeK8CPQC7auoYcMzuP3GINW3cTUFU4nVVJOjch27SwnQoykICFEmSIASdYBlxEdcG9r539UAswLzzuwMstwtocGEdPepg_cUSXmF3kX7kcKIgXOO2yELmYgKUpYQggA9nzBctaO1dnmTJWX2W5-sljZ8oVNsvOOb-tNwOgQciqTexroeT81nTm_BNLwKi\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.rl-legal.com\/cases-millendo-therapeutics-inc<\/a>.<\/p>\n<p align=\"justify\">You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1LFDmvzEKgdIr2vZLCxhty99AQ6gn3xXOYiHWVGZl0hB_vcWzP85LwkLlbe0_gEJ5Mb0fCHluzzpisP7xo0dJw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@rl-legal.com<\/a>.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8MnPU6LxdYyyQOGl7CM6973o5REuzT2Ofk9WuBAS1KEknMrrK9-uxXF83JbU8Dy-CTtnC2FL_s2bMGThXK8mgAT13EMf6bcXGAIyTF9AEmg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Rigrodsky Law, P.A.<\/a>, with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=092PGPiLn-LD40SZVRQxBkV3AuVf9343XxUE-HtDTWR_V_jK7bg4P1Tw1W6PGHtLGugOXRdSVS5lwUJp_8pySuahgdLfzVniwaZ5xWRckQ8wj-20HcAL-FiVznfuAtYqRGzSipxR5XJmQfka10Ny-w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">securities fraud and corporate class actions<\/a> nationwide.<\/p>\n<p>Attorney advertising.\u00a0 Prior results do not guarantee a similar outcome.<\/p>\n<p>CONTACT: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>Rigrodsky Law, P.A.<br \/>Seth D. Rigrodsky<br \/>Gina M. Serra<br \/>(888) 969-4242 (Toll Free)<br \/>(302) 295-5310<br \/>Fax: (302) 654-7530<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1LFDmvzEKgdIr2vZLCxht_Ei-DA7If4n4Kh8k0qSaeivrQ-1x6hHJITSzAan8EPE4ilL6kALuOyG-JnsiXIlzg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@rl-legal.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CKnZeK8CPQC7auoYcMzuP1WQ7i49Chle76zSdCAOh10IizlcDAlle39DPUKJmhkRou-nvEXjjbfpt4ntDDGGQw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/rl-legal.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4e4e3d5b-11a3-4c51-bae6-23a3ed4287f6\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WILMINGTON, Del., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Rigrodsky Law, P.A. announces that it is investigating Millendo Therapeutics, Inc. (\u201cMillendo\u201d) (NASDAQ GS: MLND) regarding possible breaches of fiduciary duties and other violations of law related to Millendo\u2019s agreement to merge with Tempest Therapeutics, Inc. To learn more about this investigation and your rights, visit: https:\/\/www.rl-legal.com\/cases-millendo-therapeutics-inc. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorney advertising.\u00a0 Prior results do not guarantee a similar outcome. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470967","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WILMINGTON, Del., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Rigrodsky Law, P.A. announces that it is investigating Millendo Therapeutics, Inc. (\u201cMillendo\u201d) (NASDAQ GS: MLND) regarding possible breaches of fiduciary duties and other violations of law related to Millendo\u2019s agreement to merge with Tempest Therapeutics, Inc. To learn more about this investigation and your rights, visit: https:\/\/www.rl-legal.com\/cases-millendo-therapeutics-inc. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorney advertising.\u00a0 Prior results do not guarantee a similar outcome. &hellip; Continue reading &quot;SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-05T16:30:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger\",\"datePublished\":\"2021-04-05T16:30:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/\"},\"wordCount\":161,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/\",\"name\":\"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=\",\"datePublished\":\"2021-04-05T16:30:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger - Market Newsdesk","og_description":"WILMINGTON, Del., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Rigrodsky Law, P.A. announces that it is investigating Millendo Therapeutics, Inc. (\u201cMillendo\u201d) (NASDAQ GS: MLND) regarding possible breaches of fiduciary duties and other violations of law related to Millendo\u2019s agreement to merge with Tempest Therapeutics, Inc. To learn more about this investigation and your rights, visit: https:\/\/www.rl-legal.com\/cases-millendo-therapeutics-inc. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorney advertising.\u00a0 Prior results do not guarantee a similar outcome. &hellip; Continue reading \"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-05T16:30:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger","datePublished":"2021-04-05T16:30:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/"},"wordCount":161,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/","name":"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=","datePublished":"2021-04-05T16:30:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTUyNyM0MTA1OTUxIzIwMjg5Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-law-p-a-announces-investigation-of-millendo-therapeutics-inc-merger\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470967"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470967\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}